ROSSI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.577
EU - Europa 762
AS - Asia 375
SA - Sud America 34
AF - Africa 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.779
Nazione #
US - Stati Uniti d'America 1.539
IT - Italia 317
CN - Cina 184
IE - Irlanda 97
JP - Giappone 59
GB - Regno Unito 56
SE - Svezia 55
ES - Italia 39
DE - Germania 35
UA - Ucraina 27
VN - Vietnam 27
KR - Corea 26
FR - Francia 23
CA - Canada 22
PL - Polonia 19
IN - India 15
NL - Olanda 15
HK - Hong Kong 14
AR - Argentina 13
CH - Svizzera 13
MX - Messico 13
SG - Singapore 11
AU - Australia 10
PT - Portogallo 10
DK - Danimarca 9
FI - Finlandia 9
BE - Belgio 8
GR - Grecia 8
PE - Perù 8
PH - Filippine 8
RO - Romania 8
TR - Turchia 8
AT - Austria 7
EG - Egitto 7
IR - Iran 6
TW - Taiwan 6
TN - Tunisia 5
BR - Brasile 4
CO - Colombia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
EU - Europa 3
IL - Israele 3
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
NO - Norvegia 2
PK - Pakistan 2
TH - Thailandia 2
VE - Venezuela 2
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
HR - Croazia 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.779
Città #
Ann Arbor 282
Chandler 207
Fairfield 115
Dublin 95
Torino 77
Wilmington 71
Ashburn 61
Beijing 50
Houston 47
Turin 40
Cambridge 39
Redwood City 37
Nyköping 33
Woodbridge 33
Seattle 31
Medford 24
Princeton 23
Dong Ket 21
Los Angeles 20
Shanghai 19
Jacksonville 18
Pisa 15
Tokyo 15
Milan 11
New York 11
Boston 10
Dearborn 10
Hangzhou 10
Seoul 10
Warsaw 9
Buffalo 8
Córdoba 8
Guangzhou 8
Rome 8
San Diego 8
Athens 7
Brussels 7
Lisbon 7
Mexico 7
Nanjing 7
Shenyang 7
Villeurbanne 7
Changsha 6
Chengdu 6
Milwaukee 6
Upper Marlboro 6
Washington 6
Wroclaw 6
Chongqing 5
Fremont 5
Lima 5
Madrid 5
Manchester 5
Munich 5
Pavia 5
Perth 5
Rivoli 5
Sheffield 5
Singapore 5
Vienna 5
Zhengzhou 5
Acton 4
Amsterdam 4
Ankara 4
Buenos Aires 4
Guiyang 4
Hefei 4
Modena 4
Ottawa 4
Paris 4
Riverton 4
Rochester 4
Sharif 4
Silver Spring 4
Zurich 4
Atlanta 3
Barcelona 3
Berlin 3
Chaoyang 3
Copenhagen 3
Düsseldorf 3
Florence 3
Glen Cove 3
Guadalajara 3
Hebei 3
Hollywood 3
Hong Kong 3
Jesi 3
Jinan 3
Leiden 3
North Olmsted 3
Norwalk 3
Parma 3
Pontevedra 3
Rickmansworth 3
San Mateo 3
Santa Maria 3
Santander 3
Taguig 3
Taoyuan District 3
Totale 1.765
Nome #
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 405
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 320
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 185
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 179
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 166
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 156
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 125
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 117
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 115
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 99
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 89
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 85
A role for GDNF and soluble APP as biomarkers of amyotrophic lateral sclerosis pathophysiology 84
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 82
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 78
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 76
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 67
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 59
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 51
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab 50
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response 48
Nailfold Capillaroscopy Patterns 46
Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort 42
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy 38
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions 25
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 23
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 20
Renal Fibrosis in Lupus Nephritis 17
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App 15
Daratumumab monotherapy for refractory lupus nephritis 11
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 11
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management 1
Totale 2.885
Categoria #
all - tutte 8.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 26 13
2019/2020309 11 12 15 23 20 27 38 34 35 30 35 29
2020/2021447 16 28 28 18 68 57 20 53 44 36 19 60
2021/2022712 21 26 41 58 70 75 87 66 70 41 83 74
2022/2023694 57 65 33 52 44 156 45 40 96 18 53 35
2023/2024384 60 65 41 33 49 31 23 25 18 34 5 0
Totale 2.885